Expertise in
6
conditions

Odd T. Brustugun

Oslo, NO 
Expertise in
6
conditions
Oslo, NO 

Overview

Odd Brustugun practices practicing medicine in Oslo, Norway.

Brustugun is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

They are actively involved in clinical research, co-authoring 130 peer reviewed articles and participating in 1 clinical trial.

Locations

Oslo, Norway
Other Locations
Drammen, Norway
Nydalen, 0424, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum -Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum -Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L)
Enrollment Status: Completed
Publish Date: June 18, 2026
Intervention Type: Biological, Drug
Study Drugs: Niraparib, Pembrolizumab
Study Phase: Phase 3

130 Total Publications

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.
Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.
Journal: Molecular cancer
Published: February 27, 2026

Frequently Asked Questions about Odd T. Brustugun

Is Odd T. Brustugun a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Odd T. Brustugun is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Odd T. Brustugun participate in research or clinical trials?

Yes. Odd T. Brustugun has published 130 articles and abstracts on conditions like Lung Cancer. You can view a list of Odd T. Brustugun's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Brustugun's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile